First International Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,762
Closed -$212K 63
2025
Q2
$212K Sell
8,762
-300
-3% -$7K 0.07% 59
2025
Q1
$230K Hold
9,062
0.07% 65
2024
Q4
$240K Buy
+9,062
New +$246K 0.08% 66
2023
Q4
Sell
-6,700
Closed -$222K 75
2023
Q3
$222K Sell
6,700
-600
-8% -$21.2K 0.08% 69
2023
Q2
$268K Hold
7,300
0.09% 82
2023
Q1
$298K Hold
7,300
0.1% 81
2022
Q4
$374K Buy
7,300
+300
+4% +$14.4K 0.13% 64
2022
Q3
$306K Hold
7,000
0.12% 68
2022
Q2
$367K Sell
7,000
-48
-0.7% -$2.45K 0.13% 58
2022
Q1
$365K Buy
7,048
+48
+0.7% +$2.49K 0.12% 60
2021
Q4
$413K Buy
+7,000
New +$347K 0.14% 51

Other funds holding PFE

First International Bank & Trust's PFE Position: Q3 2025 in Review

First International Bank & Trust sold out of Pfizer (PFE) in Q3 2025, closing a stake of 8,762 shares — an estimated $212K sold.

First International Bank & Trust first reported a position in PFE in Q4 2021 and held it in 11 quarters. The position peaked at $413K in Q4 2021. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • First International Bank & Trust reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • First International Bank & Trust sold 8,762 Pfizer shares in Q3 2025, an estimated $212K.
  • First International Bank & Trust first reported a position in Pfizer in Q4 2021 and held it in 11 quarters.
  • First International Bank & Trust's Pfizer position peaked at $413K in Q4 2021.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on First International Bank & Trust's 13F filing for Q3 2025, filed 7 Oct 2025.